TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11215011

Group type: EXPERIMENTAL
Intervention: Photography as an aid to skin examinations
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no photographs received)
Number of subjects: 0
Study: 8602598

Group type: EXPERIMENTAL
Intervention: Gum arabic (50 g/d)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo (1 g pectin/d)
Number of subjects: 16
Study: 1418062

Group type: EXPERIMENTAL
Intervention: salbutamol 200 micrograms
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: bitolterol mesilate 740 micrograms
Number of subjects: 30
Study: 6372073

Group type: EXPERIMENTAL
Intervention: Trimipramine 50 mg at night
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 29668213

Group type: EXPERIMENTAL
Intervention: EHR tools and patient engagement for high-risk patients
Number of subjects: 7691

Group type: EXPERIMENTAL
Intervention: EHR tools and patient engagement for low-risk patients
Number of subjects: 7691

Group type: COMPARATOR
Intervention: Prescription of ACE inhibitor or ARB for high-risk patients
Number of subjects: 7691

Group type: COMPARATOR
Intervention: Prescription of ACE inhibitor or ARB for low-risk patients
Number of subjects: 7691
Study: 26913411

Group type: EXPERIMENTAL
Intervention: Dexamethasone (Dex)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no dexamethasone)
Number of subjects: 30
Study: 25241986

Group type: EXPERIMENTAL
Intervention: Venlafaxine (75-225 mg/day)
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Paroxetine (20 mg/day)
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Milnacipran (100 mg/day)
Number of subjects: 249
Study: 22579379

Group type: COMPARATOR
Intervention: EBRT 39 Gy in 13 fractions
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: EBRT + CXRT boost, 85 Gy in three fractions
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Patients with complete CR
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Patients with CR ≥ 50%
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Patients with CR <50%
Number of subjects: 88
Study: 20183737

Group type: EXPERIMENTAL
Intervention: High hypnotizability
Number of subjects: 124

Group type: COMPARATOR
Intervention: IES total
Number of subjects: 124
Study: 18844799

Group type: EXPERIMENTAL
Intervention: City nurse intervention on three acute wards
Number of subjects: 3

Group type: COMPARATOR
Intervention: Control wards (five wards)
Number of subjects: 3
Study: 11535321

Group type: EXPERIMENTAL
Intervention: Twinrix (720 EL.U inactivated hepatitis A antigen and 20 mcg recombinant hepatitis B surface antigen per milliliter) on a 0, 1, 6 month schedule
Number of subjects: 773

Group type: COMPARATOR
Intervention: Havrix (1440 EL.U/ml of hepatitis A antigen at 0, 6 months) and Engerix-B (20 mcg of hepatitis B surface antigen at 0, 1, 6 months)
Number of subjects: 773
Study: 9466161

Group type: EXPERIMENTAL
Intervention: Milnacipran 200 mg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Clomipramine 150 mg/day
Number of subjects: 0
Study: 7948450

Group type: EXPERIMENTAL
Intervention: Plasma KYN concentration in patients with endogenous anxiety
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Plasma KYN concentration in patients with endogenous depression
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Post-treatment plasma KYN concentration
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Correlation of plasma KYN concentration with severity of anxiety
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Dexamethasone Suppression Test (DST) and Diazepam Test (DT)
Number of subjects: 30
Study: 2467447

Group type: EXPERIMENTAL
Intervention: Invasive laser therapy (He‐Ne laser irradiation)
Number of subjects: 0
Study: 30298380

Group type: EXPERIMENTAL
Intervention: Thai traditional dance group (TTDG)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 43
Study: 28992829

Group type: EXPERIMENTAL
Intervention: Brief Behavioral Therapy for Insomnia (BBT-I)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Self-monitoring and attention control (SMAC)
Number of subjects: 62
Study: 23837530

Group type: EXPERIMENTAL
Intervention: 4-month graft healing period
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 6-month graft healing period
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 8-month graft healing period
Number of subjects: 24
Study: 23072263

Group type: EXPERIMENTAL
Intervention: Memantine (15 mg/day for 5 days)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 21548927

Group type: EXPERIMENTAL
Intervention: Mechanical ventilation with PEEP at 12 cmH(2)O with recruitment maneuvers (lung-protective strategy)
Number of subjects: 900

Group type: COMPARATOR
Intervention: Mechanical ventilation with PEEP at maximum 2 cmH(2)O without recruitment maneuvers (conventional strategy)
Number of subjects: 900
Study: 18822904

Group type: EXPERIMENTAL
Intervention: Traditional Chinese Medicine (TCM)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Randomized distribution sequence producing
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Blinded method
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Inclusion criteria
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Exclusion criteria
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Participant flow
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Patients' compliance
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Concrete P value
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Adverse events
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Limitations discussion
Number of subjects: 46
Study: 17147039

Group type: EXPERIMENTAL
Intervention: Vestibular electrical stimulation (group 1)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Oculomotor rehabilitation (group 2)
Number of subjects: 28
Study: 12911359

Group type: EXPERIMENTAL
Intervention: Disposable metal laryngoscope blade
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Plastic disposable laryngoscope blades
Number of subjects: 60

Group type: COMPARATOR
Intervention: Reusable Macintosh 3 laryngoscope blade
Number of subjects: 60
Study: 10853616

Group type: EXPERIMENTAL
Intervention: Labetalol
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: S,R-labetalol
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: S,S-labetalol
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: R,S-labetalol
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: R,R-labetalol
Number of subjects: 19
Study: 9272336

Group type: EXPERIMENTAL
Intervention: Two-component acellular vaccine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Whole-cell vaccine
Number of subjects: 0
Study: 8096676

Group type: EXPERIMENTAL
Intervention: Intravenous acebutolol, 25 mg (acute therapy)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Chronic therapy with acebutolol, 200 mg twice daily
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Beta blockers (general use)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Carefully titrated doses of beta blockers with afterload-reducing agents
Number of subjects: 2
Study: 31777203

Group type: EXPERIMENTAL
Intervention: Sertraline 400 mg/day
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54

Group type: COMPARATOR
Intervention: Moxifloxacin 400 mg
Number of subjects: 54
Study: 29542344

Group type: EXPERIMENTAL
Intervention: 1 mg estradiol valerate daily plus 4 mg medroxyprogesterone acetate (MPA), days 19-30
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: 1 mg estradiol valerate daily plus 100 mg micronized progesterone (MP), days 19-30
Number of subjects: 96

Group type: COMPARATOR
Intervention: 100 mg C. foetida extract daily
Number of subjects: 96
Study: 27476362

Group type: EXPERIMENTAL
Intervention: Light-cured composite resin (178 brackets)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Chemical-cured composite resin (178 brackets)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Overall failure rate of brackets with both bonding systems
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Posterior teeth
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Second premolars
Number of subjects: 22
Study: 25675856

Group type: EXPERIMENTAL
Intervention: High-fat soup preload (0.8 kcal/g; 55% calories from fat)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: High-fat soup preload
Number of subjects: 75

Group type: COMPARATOR
Intervention: Water (control)
Number of subjects: 75
Study: 23134193

Group type: EXPERIMENTAL
Intervention: Acamprosate (666 mg, 3 times daily, total 1,998 mg/d)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Acamprosate and Placebo (both groups)
Number of subjects: 100
Study: 20654643

Group type: EXPERIMENTAL
Intervention: Home-based exercise (HB) with dietary counseling (100-300 calories restriction), 3 times/week, 40 min/session for 12 months
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Home-based exercise (HB) with dietary counseling (100-300 calories restriction)
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Home-based exercise (HB)
Number of subjects: 203

Group type: COMPARATOR
Intervention: Control group (CG) with dietary counseling (100-300 calories restriction)
Number of subjects: 203

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 203
Study: 18155874

Group type: EXPERIMENTAL
Intervention: Vectra Vascular Access Graft
Number of subjects: 117

Group type: COMPARATOR
Intervention: Transposed Brachial-Basilic Fistula (TBB)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Presence of arterial anastomosis stenosis treated with angioplasty
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Vectra grafts with any intra-graft, venous outflow, draining or central vein stenosis treated with angioplasty
Number of subjects: 117
Study: 16495014

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT), 4 sessions
Number of subjects: 158

Group type: COMPARATOR
Intervention: Education/attention control condition
Number of subjects: 158
Study: 12490769

Group type: EXPERIMENTAL
Intervention: Reboxetine (8‐10 mg/day)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 74

Group type: COMPARATOR
Intervention: Paroxetine (20‐40 mg/day)
Number of subjects: 74
Study: 10929902

Group type: EXPERIMENTAL
Intervention: Constipated patients with slow colonic transit
Number of subjects: 50

Group type: COMPARATOR
Intervention: Controls
Number of subjects: 50
Study: 9352392

Group type: EXPERIMENTAL
Intervention: BAY 10‐6734 (80 mg)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: BAY 10‐6734 (300 mg)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: BAY 10‐6734
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: BAY 10‐6735 (active metabolite)
Number of subjects: 24
Study: 8245114

Group type: EXPERIMENTAL
Intervention: Practice group (three 10‐minute practice sessions 1 day to 1 week before measurement)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Acclimation group (5 minutes acclimation to mouthpiece and noseclip before measurement)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control group (no practice)
Number of subjects: 27
Study: 2952029

Group type: EXPERIMENTAL
Intervention: Direct threading method of radial artery cannulation
Number of subjects: 200

Group type: COMPARATOR
Intervention: Transfixion method of radial artery cannulation
Number of subjects: 200
Study: 31492113

Group type: EXPERIMENTAL
Intervention: TV-AssistDem intervention group
Number of subjects: 240
Study: 30035585

Group type: EXPERIMENTAL
Intervention: Brief strategic therapy (BST)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Cognitive behavioral therapy (CBT)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both BST and CBT
Number of subjects: 60
Study: 26471087

Group type: EXPERIMENTAL
Intervention: 10% lidocaine spray
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 25407431

Group type: EXPERIMENTAL
Intervention: Physical exercise program including supervised group sessions, serious games approach, and specific training for severely impaired persons.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Competence training for staff members focusing on PA motivation and facilitation.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pre-, post-, and 3-month follow-up assessments in the intervention setting.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Secondary outcomes include cognitive performance and depression of residents.
Number of subjects: 0
Study: 22411302

Group type: EXPERIMENTAL
Intervention: In-clinic advocate intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care (business card referral only)
Number of subjects: 0
Study: 20634696

Group type: EXPERIMENTAL
Intervention: Intensive orthoptic therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pencil push-ups
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Base-in prism glasses
Number of subjects: 0
Study: 18036454

Group type: EXPERIMENTAL
Intervention: Oral anticoagulation (OAC)
Number of subjects: 6706

Group type: COMPARATOR
Intervention: Combined antiplatelet therapy (aspirin plus clopidogrel)
Number of subjects: 6706

Group type: EXPERIMENTAL
Intervention: Paroxysmal AF
Number of subjects: 6706

Group type: COMPARATOR
Intervention: Sustained AF
Number of subjects: 6706

Group type: EXPERIMENTAL
Intervention: OAC
Number of subjects: 6706
Study: 16169316

Group type: EXPERIMENTAL
Intervention: TIMI STEMI score
Number of subjects: 47882

Group type: EXPERIMENTAL
Intervention: Reperfusion therapy
Number of subjects: 47882

Group type: EXPERIMENTAL
Intervention: Cohort mortality rates
Number of subjects: 47882
Study: 12702735

Group type: EXPERIMENTAL
Intervention: 250 ml of a 6.4 % carbohydrate beverage (GLU trial)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Sweet placebo beverage (CON trial)
Number of subjects: 7
Study: 10680106

Group type: EXPERIMENTAL
Intervention: 2.5% glucose solution (Group G)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Ringer's solution (Group R)
Number of subjects: 20
Study: 8708587

Group type: EXPERIMENTAL
Intervention: Intensive advice (group sessions led by a health care professional)
Number of subjects: 384

Group type: EXPERIMENTAL
Intervention: Pharmacological treatment (pravastatin)
Number of subjects: 384

Group type: COMPARATOR
Intervention: Usual advice
Number of subjects: 384

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 384
Study: 1660502

Group type: EXPERIMENTAL
Intervention: Wheat bran with additional fluid (600 mL)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Wheat bran without additional fluid
Number of subjects: 11
Study: 6895918

Group type: EXPERIMENTAL
Intervention: Carbenicillin indanyl sodium (2 tablets, 4 times daily, 24 hours before and after biopsy)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo (2 tablets, 4 times daily, 24 hours before and after biopsy)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Carbenicillin indanyl sodium
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study: 30836804

Group type: EXPERIMENTAL
Intervention: Culturally tailored 1-month (8-session) intervention
Number of subjects: 233

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 233
Study: 28515057

Group type: EXPERIMENTAL
Intervention: Exercise therapy alone
Number of subjects: 118

Group type: COMPARATOR
Intervention: Early reconstruction plus exercise therapy
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Delayed reconstruction
Number of subjects: 118
Study: 27086041

Group type: EXPERIMENTAL
Intervention: Monthly oral doses of 60,000 IU of cholecalciferol
Number of subjects: 21315

Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 21315
Study: 24485000

Group type: EXPERIMENTAL
Intervention: RYGB in conjunction with omentectomy
Number of subjects: 81

Group type: COMPARATOR
Intervention: RYGB alone
Number of subjects: 81
Study: 21946392

Group type: EXPERIMENTAL
Intervention: Aliskiren (300 mg daily)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Olmesartan (40 mg daily)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination therapy (Aliskiren + Olmesartan)
Number of subjects: 0
Study: 18603228

Group type: EXPERIMENTAL
Intervention: Self-management skills to reduce drooling
Number of subjects: 10
Study: 17721009

Group type: EXPERIMENTAL
Intervention: Lipophilic statins (atorvastatin, fluvastatin, pitavastatin, simvastatin)
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: Hydrophilic statins (pravastatin)
Number of subjects: 241
Study: 16135917

Group type: EXPERIMENTAL
Intervention: Wide excision (WE) plus lymphatic mapping/sentinel node biopsy (LM/SNB) with immediate complete lymphadenectomy (CLND) for sentinel node (SN) metastases
Number of subjects: 2001

Group type: COMPARATOR
Intervention: Wide excision (WE) plus observation (WEO) with delayed CLND for nodal recurrence
Number of subjects: 2001
Study: 12186986

Group type: EXPERIMENTAL
Intervention: Laparoscopically assisted vaginal hysterectomy (LAVH)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Total laparoscopic hysterectomy (TLH)
Number of subjects: 101
Study: 10423466

Group type: EXPERIMENTAL
Intervention: Stent implantation and abciximab
Number of subjects: 2399

Group type: COMPARATOR
Intervention: Stent implantation and placebo
Number of subjects: 2399

Group type: EXPERIMENTAL
Intervention: Balloon angioplasty and abciximab
Number of subjects: 2399

Group type: EXPERIMENTAL
Intervention: Stenting plus abciximab vs Angioplasty plus abciximab
Number of subjects: 2399

Group type: COMPARATOR
Intervention: Stenting and placebo
Number of subjects: 2399

Group type: EXPERIMENTAL
Intervention: Angioplasty and abciximab
Number of subjects: 2399
Study: 7741168

Group type: EXPERIMENTAL
Intervention: Bacitracin zinc (120,000 U, 10-day treatment)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Bacitracin (120,000 U, 10-day treatment)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Neomycin (120,000 U, 10-day treatment)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Bacitracin zinc plus Neomycin (60,000 U each, 10-day treatment)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Bacitracin zinc
Number of subjects: 102

Group type: COMPARATOR
Intervention: Bacitracin
Number of subjects: 102

Group type: COMPARATOR
Intervention: Neomycin
Number of subjects: 102

Group type: COMPARATOR
Intervention: Bacitracin zinc plus Neomycin
Number of subjects: 102
Study: 2184003

Group type: EXPERIMENTAL
Intervention: Amoxicillin/clavulanic acid
Number of subjects: 0
Study: 7260183

Group type: EXPERIMENTAL
Intervention: Success group (received false feedback and instructions that conveyed successful control)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Failure group (received feedback and instructions that conveyed outcomes had not been controlled)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (given no specific task)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: All groups during test stage (asked to reduce frontal muscle tension levels through relaxation with true EMG feedback)
Number of subjects: 48
Study: 31581815

Group type: EXPERIMENTAL
Intervention: Standard analysis methods applied to data from a biomarker-stratified outcome-adaptive randomization trial
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Proposed adjusted estimators
Number of subjects: 0
Study: 28733805

Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA 24 U
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA 12 U
Number of subjects: 300

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300
Study: 26473191

Group type: EXPERIMENTAL
Intervention: Targeted anticancer agents in Phase III RCTs
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 0
Study: 23337270

Group type: EXPERIMENTAL
Intervention: Ankle block administered after inflation of tourniquet (Group A)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Ankle block administered before inflation of tourniquet (Group B)
Number of subjects: 60
Study: 21147163

Group type: EXPERIMENTAL
Intervention: Physostigmine infusion (cholinergic challenge)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (age-gender-education matched veterans)
Number of subjects: 0
Study: 20939783

Group type: EXPERIMENTAL
Intervention: Randomized controlled trials (RCTs) involving orthopedic implants
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Study design improvements
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Challenges in RCTs
Number of subjects: 0
Study: 18175843

Group type: EXPERIMENTAL
Intervention: Paracetamol (15 mg/kg)
Number of subjects: 210
Study: 15088870

Group type: EXPERIMENTAL
Intervention: Calcium sulfate (CS) combined with demineralized freeze-dried bone allograft (DFDBA)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Polytetrafluoroethylene (ePTFE) combined with demineralized freeze-dried bone allograft (DFDBA)
Number of subjects: 19
Study: 10688340

Group type: EXPERIMENTAL
Intervention: Low TENS treatment
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 28
Study: 9058222

Group type: EXPERIMENTAL
Intervention: Atracurium
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Vecuronium
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Atracurium and Vecuronium
Number of subjects: 20
Study: 1558292

Group type: EXPERIMENTAL
Intervention: Alcohol (0.8 ml of 100% alcohol/kg body weight)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control
Number of subjects: 30
Study: 6234558

Group type: EXPERIMENTAL
Intervention: Microgranules of dihydroergotamine (30 mg/24 hours)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Dihydroergotamine solution (similar dose)
Number of subjects: 30
Study: 30468761

Group type: EXPERIMENTAL
Intervention: Pneumatic retinopexy (PnR)
Number of subjects: 176

Group type: COMPARATOR
Intervention: Pars plana vitrectomy (PPV)
Number of subjects: 176
Study: 29533110

Group type: EXPERIMENTAL
Intervention: Postoperative immunomodulating enteral nutrition (Reconvan, Fresenius Kabi)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Standard enteral nutrition (Peptisorb, Nutricia)
Number of subjects: 98
Study: 27147077

Group type: EXPERIMENTAL
Intervention: Laser acupuncture (low-level laser 650 nm with 50 mW power applied at each acupoint for 30 s, energy density of 1.8 J/cm²)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Physiotherapy (3 months duration for both groups)
Number of subjects: 40